Detalles de la búsqueda
1.
Development and validation of a nomogram model for all-cause mortality risk in patients with chronic heart failure and atrial fibrillation.
BMC Geriatr
; 24(1): 470, 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38811919
2.
Effects of Empagliflozin on Gut Microbiota in Heart Failure with a Preserved Ejection Fraction: The Design of a Pragmatic Randomized, Open-Label Controlled Trial (EMPAGUM).
Drug Des Devel Ther
; 17: 1495-1502, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37223722
3.
Risk prediction model of in-hospital mortality in heart failure with preserved ejection fraction and mid-range ejection fraction: a retrospective cohort study.
Biomark Med
; 15(14): 1223-1232, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34498488
4.
Shock Index, Modified Shock Index, and Age-Adjusted Shock Index in Predicting the In-Hospital Mortality in Patients with Heart Failure and Chronic Kidney Disease.
Biomed Environ Sci
; 36(3): 279-283, 2023 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37005081
5.
Prognostic Utility of Serum Cystatin C/FT3 Ratio Combined with NT-proBNP in Patients with Heart Failure: A Retrospective Cohort Study.
Biomed Environ Sci
; 35(5): 453-457, 2022 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35676816
Resultados
1 -
5
de 5
1
Próxima >
>>